Venmax Drugs And Pharmaceuticals Ltd.

Financial

	Venmax Drugs&Pharma	Ortin Global	Parmax Pharma
Operational Metrics
Financials
5 yr Average ROE	-44.32 %	-57.26 %	-1624.87 %
5yr average Equity Multiplier	-0.19	2.67	46.04
5yr Average Asset Turnover Ratio	0.32	0.6	0.95
5yr Avg Net Profit Margin	-30.94 %	-75.26 %	-9.48 %
Price to Book	2.96	6.58	0.0
P/E	0.0	0.0	0.0
5yr Avg Cash Conversion Cycle	0.0	597.13 Days	-161.05 Days
Inventory Days	24.83 Days	335.19 Days	73.65 Days
Days Receivable	0.0	448.05 Days	40.27 Days
Days Payable	189.56 Days	649.97 Days	328.05 Days
5yr Average Interest Coverage Ratio	-318.36	-2.05	1.16
5yr Avg ROCE	-45.33 %	-24.19 %	-9.94 %
5yr Avg Operating Profit Margin	-50.41 %	-55.65 %	3.93 %
5 yr average Debt to Equity	-0.64	0.64	17.42
5yr CAGR Net Profit	n/a	44.41 %	n/a
5yr Average Return on Assets	187.49 %	-20.66 %	-6.43 %
Shareholdings
Promoter Holding	23.13 %	1.23 %	30.8 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-14.45 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0